Expression of COX-2 and Its Significance in Breast Cancer

王西京,代志军,赵世平,刘小旭,康华峰,薛锋杰
DOI: https://doi.org/10.3969/j.issn.1673-5269.2004.12.008
2004-01-01
Abstract:OBJECTIVE:To study the expression of COX-2 and its clinicopathological significance in human breast cancer.METHODS: Archival breast carcinomas (n=80), atypical hyperplasia (n=27) and normal breast epithelia (n=20) were analyzed for COX-2 expression by immunohistochemistry using specific monoclonal antibodies.RESULTS: Fifty-seven point five percent (46/80) of breast carcinomas expressed COX-2 at a moderate to high level, which was significantly different from the expression in the benign and normal breast epithelia. COX-2 expression was correlated with the histological grade, lymphnode metastasis, TNM stage,P0.05 or P0.01. The 5- year DFS of the COX-2 negative group was significantly higher than that of the COX-2 positive group in breast cancer,P0.05. CONCLUSIONS: COX-2 may be a useful marker for reflecting tumor malignant behavior and estimating prognosis of human breast cancer.
What problem does this paper attempt to address?